Skip to main content

Table 1 Thymic epithelial tumors characteristics

From: Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1

 

N = 103 patients

Histology WHO 2015

 Thymoma B2/B3

18 (17%)

 Thymoma B3

35 (34%)

 Thymoma B3/C

4 (4%)

 Thymic carcinoma

46 (45%)

Type

 Biopsy

20 (19%)

 Surgical resection

83 (81%)

Tumor

 Initial resection

89 (86%)

 Recurrence

4 (4%)

 Metastasis

10 (10%)